Methoxypoly(ethylene glycol)-conjugated carboxypeptidase A for solid tumor targeting: part II: pharmacokinetics and biodistribution in normal and tumor-bearing rodents.

Methoxypoly(ethylene glycol)-conjugated carboxypeptidase A for solid tumor targeting: part II: pharmacokinetics and biodistribution in normal and tumor-bearing rodents.
复制标题

用于实体瘤靶向的甲氧基聚(乙二醇)缀合的羧肽酶 A:第二部分:正常和荷瘤啮齿动物中的药代动力学和生物分布。

DOI:
10.1016/j.jconrel.2005.01.015
复制
发表时间:
2005
期刊:
Journal of controlled release : official journal of the Controlled Release Society.
影响因子:
--
通讯作者:
Kwon,GlenS
Kwon,GlenS
中科院分区:
--
文献类型:
--
作者:
Ton,GiangthyN;Weichert,JameyP;Longino,MarcA;Fine,JasonP;Kwon,GlenS

文献摘要

被引文献

相似文献

我们评价了mpeg修饰对羧基肽酶A(CPA)在正常大鼠体内药代动力学特性的影响。将两条或三条mpeg链连接到CPA上会导致MPEG2-CPA和mPEG3-CPA类似物的产生,其血浆半衰期显著增加,特别是在分布阶段。此外,对CT26荷瘤小鼠的实时全身动力学评估表明,MPEG2-CPA和mPEG3-CPA在注射后48小时均表现出较高的体内滞留。此外,mPEG3-CPA在72h的肿瘤定位通过γ-闪烁成像和MicroCT数据集的融合而被可视化和确认。影像研究的结果支持了我们的假设,即肿瘤摄取与增强的循环半衰期之间存在相关性。组织分布数据显示,在给药后48h,MPEG2-CPA观察到的肿瘤渗出增加和有效的肾脏消除相结合,导致肿瘤与血液的最高比率为4.8:1。虽然在预定的时间间隔内,mPEG3-CPA在肿瘤中的累积总浓度高于MPEG2-CPA和CPA,但由于血液活性水平较高,并未获得更高的肿瘤与血液比率。显然,连接适当数量的mpeg链可以像使用肿瘤特异性抗体一样有效地促进肿瘤的定位。
We have evaluated effects of mPEG modification on pharmacokinetic properties of carboxypeptidase A (CPA) in normal rats. Attachment of two or three mPEG chains to CPA resulted in the generation of mPEG2–CPA and mPEG3–CPA analogs with significantly enhanced plasma half-lives, especially during the distribution phase. Moreover, the assessment of real-time whole-body kinetics in CT26 tumor-bearing mice showed both mPEG2–CPA and mPEG3–CPA exhibited increased body retention at 48 h post-injection. In addition, tumor localization of mPEG3–CPA at 72 h was visualized and confirmed by fusion of the γ-scintigraphy and microCT data sets. Results from the imaging studies support our hypothesis of a correlation between tumor uptake and enhanced circulatory half-life. Tissue distribution data indicated the combination of increased tumor extravasation and effective renal elimination observed with mPEG2–CPA at 48 h following administration led to the highest observed tumor-to-blood ratio of 4.8:1. Although the total concentration of mPEG3–CPA accumulated in tumor was higher than that of mPEG2–CPA and CPA at predetermined time intervals, a higher tumor-to-blood ratio was not obtained owing to a higher level of blood activity. Clearly, the attachment of an appropriate number of mPEG chains can facilitate tumor localization as effectively as can the use of a tumor-specific antibody.